BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 6193919)

  • 1. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers in oncological gynecology].
    Vishnevskiĭ AS
    Vopr Onkol; 1984; 30(8):23-34. PubMed ID: 6207663
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor markers in the ovarian carcinoma.
    Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
    Tottori K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour antigens associated with primary mediastinal choriocarcinoma.
    Forest JC; Talbot J; Pagé M; Loiselle JM
    Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor associated markers in clinical diagnosis.
    Rochman H
    Ann Clin Lab Sci; 1978; 8(3):167-75. PubMed ID: 77652
    [No Abstract]   [Full Text] [Related]  

  • 8. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers in gynecologic cancers. An overview.
    Dini MM; Miller M
    IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of tumor markers in cancer of the ovary.
    Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fetal and placental proteins in ovarian cancer].
    Tatra G; Ludwig H
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():138-41. PubMed ID: 6163685
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial determination of marker substances in ovarian cancer.
    Stanhope CR; Smith JP; Britton JC; Crosley PK
    Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437
    [No Abstract]   [Full Text] [Related]  

  • 13. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
    Kurman RJ; Ganjei P; Nadji M
    Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum markers in malignant diseases].
    Peter HH
    Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor markers.
    Ewing HP; Newsom BD; Hardy JD
    Curr Probl Surg; 1982 Feb; 19(2):53-94. PubMed ID: 6175486
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of tumor markers in clinical oncology].
    Gericke D; Drahovsky D
    Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method].
    Tanimura T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2344-52. PubMed ID: 2416855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
    Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
    Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.